AbSorber is pleased to announce the appointment of Anders Karlsson as Chief Operating Officer (COO). Karlsson joins AbSorber from Novartis, where he was CEO for the company's operations in Norway. He has earlier also been Director of Sales for the transplantation business area at Sandoz.
"AbSorber needs a commercially orientated organization that supports the company's growth and sales of XM-ONE as the company start to accelerate. We are therefore delighted to appoint Anders Karlsson, who has extensive knowledge of the transplantation industry and is an experienced manager to this newly established position," says Ingemar Lagerlöf, CEO of AbSorber.
In the role of COO, Karlsson will be responsible for the operational side of AbSorber's business, encompassing the production and sales of XM-ONE, as well as the development of new products.
Karlsson will also support AbSorber's partner BD in its work to introduce and market XM-ONE in markets outside the Nordic region. AbSorber develops products that facilitate successful transplantations. The company's first product, the transplantation test XM-ONETM identifies important antibodies responsible for rejection subsequent
to transplantation. The company is also developing an AB0 Column for transplantations between individuals of different blood groups for which a patent is pending and an AB0 diagnostic tool that measures the occurrence of blood group antibodies.
For further information contact:
Ingemar Lagerlöf, CEO AbSorber, Tel +46 8 50 89 39 93 or ingemar.lagerlof@absorber.se